IRISanRaf

BARBANTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.239
AS - Asia 3.631
EU - Europa 1.267
SA - Sud America 459
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 81
OC - Oceania 13
Totale 10.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.730
TR - Turchia 1.061
SG - Singapore 924
CN - Cina 752
IT - Italia 630
CA - Canada 459
BR - Brasile 346
VN - Vietnam 284
BD - Bangladesh 166
IN - India 96
HK - Hong Kong 94
FR - Francia 92
DE - Germania 90
GB - Regno Unito 74
UA - Ucraina 72
IE - Irlanda 71
EU - Europa 65
PK - Pakistan 59
RU - Federazione Russa 58
AR - Argentina 42
ID - Indonesia 37
IL - Israele 37
FI - Finlandia 36
NL - Olanda 34
ES - Italia 25
MX - Messico 25
EC - Ecuador 17
ZA - Sudafrica 17
CO - Colombia 16
SC - Seychelles 16
JP - Giappone 15
IQ - Iraq 14
MY - Malesia 14
PL - Polonia 14
VE - Venezuela 14
SE - Svezia 13
PH - Filippine 12
KE - Kenya 11
AU - Australia 10
CL - Cile 8
EG - Egitto 8
KZ - Kazakistan 8
PY - Paraguay 7
SA - Arabia Saudita 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
MA - Marocco 6
NP - Nepal 6
RO - Romania 6
TN - Tunisia 6
UZ - Uzbekistan 6
CR - Costa Rica 5
IR - Iran 5
KR - Corea 5
PT - Portogallo 5
RS - Serbia 5
TW - Taiwan 5
DK - Danimarca 4
JO - Giordania 4
MD - Moldavia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BE - Belgio 2
BG - Bulgaria 2
BW - Botswana 2
CU - Cuba 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
Totale 10.744
Salva come PNG Salva come JPEG
Città #
Kocaeli 926
San Mateo 664
Dallas 628
San Jose 600
Toronto 423
Ashburn 409
Rome 380
Singapore 282
Santa Clara 225
Beijing 223
Wilmington 223
Council Bluffs 195
Houston 182
Lawrence 140
Princeton 140
Phoenix 139
Ho Chi Minh City 115
Hong Kong 90
Los Angeles 79
Fairfield 74
Seattle 60
New York 58
Hanoi 54
Chandler 49
West Jordan 46
Islamabad 45
Redwood City 43
Shanghai 43
Frankfurt am Main 41
São Paulo 41
Woodbridge 34
Milan 31
Netanya 31
Brooklyn 30
Guangzhou 26
Helsinki 26
Cambridge 25
Dublin 24
Chicago 18
Jakarta 15
Mexico City 15
Orem 15
Shenzhen 13
Vicenza 13
Amsterdam 12
Montreal 12
Boston 11
Haiphong 11
Kuala Selangor 11
London 11
Munich 11
Rio de Janeiro 11
Tokyo 11
Buffalo 10
Nairobi 10
Suffern 10
Atlanta 9
Denver 9
Miami 9
Charlotte 8
Florence 8
Naples 8
Saint Petersburg 8
San Francisco 8
Andover 7
Biên Hòa 7
Chennai 7
Curitiba 7
Da Nang 7
Dhaka 7
Johannesburg 7
Las Vegas 7
Mumbai 7
Philadelphia 7
Quito 7
Roubaix 7
Rui'an 7
Secaucus 7
The Dalles 7
Turku 7
Washington 7
Wuhan 7
Almaty 6
Ankara 6
Bexley 6
Ha Long 6
Kansas City 6
Pune 6
St Petersburg 6
Turin 6
Warsaw 6
Wroclaw 6
Wuxi 6
Ann Arbor 5
Belo Horizonte 5
Boardman 5
Bologna 5
Borås 5
Buenos Aires 5
Guayaquil 5
Totale 7.358
Salva come PNG Salva come JPEG
Nome #
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 359
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 139
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 139
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 133
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 132
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 121
A case-control study on excessive daytime sleepiness in chronic migraine 108
A case-control study on excessive daytime sleepiness in chronic migraine 104
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 103
A case - control study on excessive daytime sleepiness in episodic migraine 102
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 100
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 94
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 94
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 90
Ketogenic diet in migraine: rationale, findings and perspectives 89
Hypertension as a risk factor for migraine chronification 84
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 83
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 83
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 83
Acupuncture in cluster headache: Four cases and review of the literature 83
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 82
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 79
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 79
A mechanism-based classification of pain in multiple sclerosis 78
Restless legs syndrome is not associated with migraine with aura: a clinical study 78
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 78
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 77
Unilateral cranial autonomic symptoms in migraine 76
Dopamine hypersensitivity in migraine: Role of the apomorphine test 74
Treatment of tension-type headache: from old myths to modern concepts 74
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 74
Acute pathological laughter induced by sumatriptan 73
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 72
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 72
Machine learning approach to predict medication overuse in migraine patients 72
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 72
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 71
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 71
Migraine as a Cortical Brain Disorder 71
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 70
Tardive dyskinesias in the elderly 70
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 69
Cluster headache: management of acute attacks before triptans 69
Future trends in drugs for migraine prophylaxis 69
Late motor recovery is influenced by muscle tone changes after stroke 68
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 68
Dopamine and migraine: Does Parkinson's disease modify migraine course? 68
Real-world insights on the management of migraine patients: an Italian nationwide study 68
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 67
A proposal for a national registry on chronic migraines 67
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 67
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 67
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 66
Migraine and Tourette syndrome 66
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 66
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 66
Pharmacotherapy for acute migraines in children and adolescents 66
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 66
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 65
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 65
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 65
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 65
Tension type headache: a neuropsychological and neurophysiological study 65
Association of LTA and SOD Gene Polymorphisms with Cerebral White Matter Hyperintensities in Migraine Patients 64
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 64
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 64
Donepezil in the treatment of progressive supranuclear palsy 64
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 64
Migraine and movement disorders 64
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 64
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire 64
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 63
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 63
Erenumab during pregnancy: a case report in a patient with chronic migraine 63
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 62
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70 61
Migraine attack delays gastric emptying: an ultrasonographic study 61
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 61
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 61
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 61
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 61
Migraine prophylaxis: what is new and what we need? 61
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 60
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 60
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire 60
Impairment of trigeminal sensory pathways in cluster headache 59
Shortened cortical silent period in facial muscles of patients with migraine 59
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 58
Socio-economic costs of migraine 58
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial 58
Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 58
Trigeminal sensory pathway function in patients with SUNCT 57
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 57
The role of dopamine in migraine 57
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 56
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 56
Drugs targeting nitric oxide synthase for migraine treatment 56
Headache in chronic cocaine users: A cross-sectional study 56
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination 55
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 55
Totale 7.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.972
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022940 0 0 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/20264.521 259 356 662 381 269 461 521 265 504 446 226 171
2026/2027608 29 459 120 0 0 0 0 0 0 0 0 0
Totale 10.989